Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion type Assertion NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_head.
- NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion wasGeneratedBy ECO_0000203 NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_provenance.
- NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion wasDerivedFrom gad-20150221 NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_provenance.
- NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion SIO_000772 20733306 NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_provenance.
- NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion evidence source_evidence_literature NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_provenance.
- NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_assertion description "[Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184278.RAtGfW3npVSJE1fMSxP05fzHnxMl1pksKqYa8We_6XtM0130_provenance.